Quantitative PCR evaluation of cellular immune responses in Kenyan children vaccinated with a candidate malaria vaccine.

Quantitative PCR evaluation of cellular immune responses in Kenyan children vaccinated with a candidate malaria vaccine.

Show other versions (1)

BACKGROUND: The T-cell mediated immune response plays a central role in the control of malaria after natural infection or vaccination. There is increasing evidence that T-cell responses are heterogeneous and that both the quality of the immune response and the balance between pro-inflammatory and re...

Full description

Bibliographic Details
Main Authors:	Mwacharo, J, Dunachie, S, Kai, O, Hill, A, Bejon, P, Fletcher, H
Format:	Journal article
Language:	English
Published:	Public Library of Science 2009

Similar Items

Quantitative PCR evaluation of cellular immune responses in kenyan children vaccinated with a candidate malaria vaccine
by: Mwacharo, J, et al.
Published: (2009)

Quantitative PCR evaluation of cellular immune responses in Kenyan children vaccinated with a candidate malaria vaccine.
by: Jedidah Mwacharo, et al.
Published: (2009-12-01)

Correction: Quantitative PCR Evaluation of Cellular Immune Responses in Kenyan Children Vaccinated with a Candidate Malaria Vaccine.
by: Jedidah Mwacharo, et al.
Published: (2011-01-01)

Correction: Quantitative PCR Evaluation of Cellular Immune Responses in Kenyan Children Vaccinated with a Candidate Malaria Vaccine
Published: (2011-01-01)

Safety, immunogenicity and efficacy studies of candidate malaria vaccines FP9 and MVA encoding ME-TRAP in Kenyan children [MIM-PB-224908]
by: Bejon, P, et al.
Published: (2005)

A seven-year study on the effect of the pre-erythrocytic malaria vaccine candidate RTS,S/AS01E on blood stage immunity in young Kenyan children
by: Ndungu, F, et al.
Published: (2019)

Regulatory T cells limit the cellular response to CS and TRAP encoding candidate malaria vaccines in humans [MIM-SD-8756]
by: Dunachie, S, et al.
Published: (2005)

A seven-year study on the effect of the pre-erythrocytic malaria vaccine candidate RTS,S/AS01E on blood stage immunity in young Kenyan children [version 1; peer review: 1 approved, 2 approved with reservations]
by: Francis M. Ndungu, et al.
Published: (2019-03-01)

Safety and immunogenicity of the candidate malaria vaccines FP9 ME-TRAP and MVA METRAP in semi-immune adult males [MIM-OK-87312]
by: Kai, O, et al.
Published: (2005)

Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children.
by: Lusingu, J, et al.
Published: (2010)

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01 in 5 to 17 Month Old Kenyan and Tanzanian Children.
by: John Lusingu, et al.
Published: (2010-01-01)

Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children.
by: John Lusingu, et al.
Published: (2010-11-01)

Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan children, in the context of vaccine vector efficacy.
by: Dudareva, M, et al.
Published: (2009)

Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME-TRAP in 1-6 year old children in a malaria endemic area.
by: Bejon, P, et al.
Published: (2006)

Feedback of Research Findings for Vaccine Trials: Experiences from Two Malaria Vaccine Trials Involving Healthy Children on the Kenyan Coast
by: Gikonyo, C, et al.
Published: (2013)

Feedback of research findings for vaccine trials: experiences from two malaria vaccine trials involving healthy children on the Kenyan Coast.
by: Gikonyo, C, et al.
Published: (2013)

Effect of the pre-erythrocytic candidate malaria vaccine RTS,S/AS01E on blood stage immunity in young children.
by: Bejon, P, et al.
Published: (2011)

Clearance of asymptomatic P. falciparum Infections Interacts with the number of clones to predict the risk of subsequent malaria in Kenyan children.
by: Liljander, A, et al.
Published: (2011)

Clearance of asymptomatic P. falciparum Infections Interacts with the number of clones to predict the risk of subsequent malaria in Kenyan children.
by: Anne Liljander, et al.
Published: (2011-01-01)

Quantitative real-time polymerase chain reaction for malaria diagnosis and its use in malaria vaccine clinical trials.
by: Andrews, L, et al.
Published: (2005)

Prime-boost strategies for malaria vaccine development.
by: Dunachie, S, et al.
Published: (2003)

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01E in 5 to 17 Month Old Kenyan and Tanzanian Children
Published: (2010-01-01)

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01E in 5 to 17 Month Old Kenyan and Tanzanian Children
Published: (2010-01-01)

PHASE IIB, RANDOMIZED, DOUBLE-BLIND TRIAL TO ASSESS THE EFFICACY, SAFETY AND IMMUNOGENICITY OF THE CANDIDATE MALARIA VACCINE RTS,S/AS01 IN KENYAN AND TANZANIAN CHILDREN
by: Bejon, P, et al.
Published: (2008)

A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya
by: Bejon, P, et al.
Published: (2006)

Early gamma interferon and interleukin-2 responses to vaccination predict the late resting memory in malaria-naive and malaria-exposed individuals.
by: Bejon, P, et al.
Published: (2006)

MIG (CXCL9) is a more sensitive measure than IFN-gamma of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccines.
by: Berthoud, T, et al.
Published: (2009)

MIG and the regulatory cytokines IL-10 and TGF-[beta]1 correlate with malaria vaccine immunogenicity and efficacy.
by: Dunachie, S, et al.
Published: (2010)

MIG and the regulatory cytokines IL-10 and TGF-β1 correlate with malaria vaccine immunogenicity and efficacy
by: Dunachie, S, et al.
Published: (2010)

The ratio of monocytes to lymphocytes in peripheral blood correlates with increased susceptibility to clinical malaria in Kenyan children.
by: Warimwe, G, et al.
Published: (2013)

MIG (CXCL9) is a more sensitive measure than IFN-gamma of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccines (vol 340, pg 33, 2009)
by: Berthoud, T, et al.
Published: (2011)

Cellular immune responses to nine Mycobacterium tuberculosis vaccine candidates following intranasal vaccination.
by: Suraj B Sable, et al.
Published: (2011-01-01)

The effects of aflatoxin exposure on Hepatitis B-vaccine induced immunity in Kenyan children
by: Githang'a, D, et al.
Published: (2019)

Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites.
by: Bejon, P, et al.
Published: (2005)

Vaccine candidate discovery for the next generation of malaria vaccines.
by: Tuju, J, et al.
Published: (2017)

Corrigendum to "MIG (CXCL9) is a more sensitive measure than IFN-γ of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccines" [J. Immunol. Methods 340 (2009) 33-41]
by: Berthoud, T, et al.
Published: (2011)

Update on the clinical development of candidate malaria vaccines.
by: Ballou, W, et al.
Published: (2004)

Steps towards a malaria vaccine
by: Bejon, P
Published: (2005)

The ratio of monocytes to lymphocytes in peripheral blood correlates with increased susceptibility to clinical malaria in Kenyan children.
by: George M Warimwe, et al.
Published: (2013-01-01)

Alternating vector immunizations encoding pre-erythrocytic malaria antigens enhance memory responses in a malaria endemic area.
by: Bejon, P, et al.
Published: (2006)